The National Cancer Institute is offering the Centers of Cancer Nanotechnology Excellence (CCNEs) grant as part of the NCI Alliance for Nanotechnology in Cancer program. This grant aims to link physical scientists, engineers, and technologists with cancer biologists and oncologists to develop new cancer care applications using nanotechnology. The CCNEs will focus on early disease diagnosis, therapeutic solutions like nanoparticle-driven immunotherapies, and cancer prevention techniques. Applicants must propose multi-project approaches showcasing expertise in cancer biology, nanotechnology, and translational research. The ultimate goal is to advance innovative cancer care applications quickly. Pre-application webinar details are available on the NCI website. Closing Date: Nov 03, 2014.
Opportunity ID: 259751
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | RFA-CA-14-013 |
| Funding Opportunity Title:: | Centers of Cancer Nanotechnology Excellence (CCNEs) (U54) |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Education |
| Category Explanation:: | |
| Expected Number of Awards:: | |
| Assistance Listings Number(s):: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Jul 17, 2014 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Nov 03, 2014 |
| Current Closing Date for Applications:: | Nov 03, 2014 |
| Archive Date:: | Dec 04, 2014 |
| Estimated Total Program Funding:: | |
| Award Ceiling:: | $ |
| Award Floor:: | $ |
Eligibility
| Eligible Applicants:: | Private institutions of higher education |
| Additional Information on Eligibility:: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name:: | National Institutes of Health |
| Description:: | This Funding Opportunity Announcement (FOA) solicits applications for Centers of Cancer Nanotechnology Excellence (CCNE) that will be a main part of the NCI Alliance for Nanotechnology in Cancer (The Alliance) program (http://nano.cancer.gov). Whereas CCNEs will form the core of the Alliance, they will be accompanied by smaller Innovative Research in Cancer Nanotechnology (IRCN) awards and T32 training programs. This FOA is open to all qualified applicants regardless of whether or not they participated in the previous issuance of the program. CCNEs are designed to link physical scientists, engineers, and technologists working at the nanoscale with cancer biologists and oncologists specializing in the diagnosis, prevention, and/or treatment of cancer to enable development and translation of new cancer care applications based on nanotechnology. CCNE awards will support the development of techniques and tools that are applicable to: early disease diagnosis using in vitro assays and devices or in vivo imaging techniques; multifunctional therapeutic solutions, including nanoparticle-driven immunotherapies; and techniques for cancer prevention and control. Multi-disciplinary research teams submitting applications should collectively have the breadth of expertise that would allow them to: (a) identify an overarching problem in cancer biology and/or oncology that can be addressed with a multi-project approach leveraging nanotechnology and (b) demonstrate the translational potential of the technologies proposed in the above mentioned projects. The overall goal is a rapid advance of novel cancer care applications based on nanotechnology.
NCI will hold a pre-application informational webinar for this FOA. Date, time, and other details will be posted at http://nano.cancer.gov/phase3info. |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 1 |
Package Status
Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:
Package No: 1
Packages
| Assistance Listings | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions | Who Can Apply: | |
|---|---|---|---|---|---|---|---|---|
| FORMS-C | Forms-C | PKG00201226 | Oct 03, 2014 | Nov 03, 2014 | View | eRA Commons Help Desk | Organization Applicants |